Drug Profile
Agalsidase beta biosimilar - JCR Pharmaceuticals/GSK
Alternative Names: Agalsidase Beta BS I.V. Infusion [JCR]; Alpha-galactosidase A - JCR/GSK; JR-051Latest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator JCR Pharmaceuticals
- Class Galactosidases; Glycoproteins; Isoenzymes; Recombinant proteins
- Mechanism of Action Alpha-galactosidase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Fabry's disease